Economic analysis of centralized vs. decentralized electronic data capture in multi-center clinical studies

Studies in Health Technology and Informatics

Volumn 164, Issue , 2011, Pages 82-88

  Walden, Anita ^a   Nahm, Meredith ^a   Barnett, M Edwina ^b   Conde, Jose G ^c   Dent, Andrew ^b   Fadiel, Ahmed ^d   Perry, Theresa ^b   Tolk, Chris ^e   Tcheng, James E ^a   Eisenstein, Eric L ^a  

^a DUKE UNIVERSITY   (United States)

^b JACKSON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d MEHARRY MEDICAL COLLEGE   (United States)

^e Clinical Data Interchange Standards Consortium   (United States)

Author keywords

Clinical research network; Clinical trial; Cost analysis; Data management

Indexed keywords

CLINICAL RESEARCH; COST BENEFIT ANALYSIS; ECONOMIC ANALYSIS;

CENTRALIZED MODELS; CLINICAL TRIAL; COST ANALYSIS; DECENTRALIZED MODELS; DESCRIPTIVE INFORMATION; MANAGEMENT COSTS; OUTCOME MEASURES; RESEARCH NETWORKS;

INFORMATION MANAGEMENT;

CLINICAL TRIAL; COST; ECONOMICS; HOSPITAL INFORMATION SYSTEM; INFORMATION SYSTEM; MULTICENTER STUDY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PROCEDURES;

COSTS AND COST ANALYSIS; HOSPITAL INFORMATION SYSTEMS; INFORMATION MANAGEMENT; MODELS, ORGANIZATIONAL;

EID: 79953053460     PISSN: 09269630     EISSN: 18798365     Source Type: Book Series    
DOI: 10.3233/978-1-60750-709-3-82     Document Type: Conference Paper

References (12)

1. L. Freidman, C.D. Furberg, D.L. DeMets, Fundamentals of Clinical Trials, 3rd edition, Mosby-Year Book, St. Louis, 1996.
2. E.R. Dorsey, J. de Roulet, J.P. Thompson, J.I. Reminick, A. Thai, Z. White-Stellato, C.A. Beck, B.P. George, H. Moses III, Funding of US biomedical research, 2003-2008, JAMA 303 (2010), 137-143.
3. E.L. Eisenstein, R. Collins, B.S. Cracknell, O. Podesta, E.E. Reid, P. Sandercock, Y. Shakhov, M.L. Terrin, M.A. Sellers, R.M. Califf, C.B. Granger, R. Diaz, Sensible approaches for reducing clinical trial costs, Clin Trials 5 (2008), 75-84. (Pubitemid 351412376)
4. H. Moses III, E.R. Dorsey, D.H. Matheson, S.O. Thier, Financial anatomy of biomedical research, JAMA 294 (2005), 1333-1342. (Pubitemid 41345812)
5. E.L. Eisenstein, M. Ortiz, K.J. Anstrom, D.F. Lobach, Health information technology economic evaluation, in: A.W. Kushniruk, E. Borcycki, editors, The Human and Social Side of Health Information Systems, 1st ed., Idea Group Publishing, Hershey, PA, 2008, 240-58.
6. M. Campbell, R. Fitzpatrick, A. Haines, A.L. Kinmouth, P. Sandercock, D. Spiegelhalter, Framework for design and evaluation of complex interventions to improve health, BMJ 321 (2000), 694-696.
7. E.L. Eisenstein, P.W. Lemons, B.E. Tardiff, K.A. Schulman, M.K. Jolly, R.M. Califf, Reducing the costs of phase III cardiovascular clinical trials, Am Heart J 149 (2005), 482-488. (Pubitemid 40585412)
8. J.S. Li, E.L. Eisenstein, H.G. Grabowski, E.D. Reid, B. Mangum, K.A. Schulman, J.V. Goldsmith, M.D. Murphy, R.M. Califf, D.K. Benjamin, Economic return of clinical trials performed under the pediatric exclusivity program, JAMA 297 (2007), 480-488. (Pubitemid 46220803)
9. C. Rozwell, R.D. Kush, E. Helton, F. Newby, T. Mason, Business Case for CDISC Standards: Summary 2006, PhRMA-Gartner-CDISC Project, 2006.
10. C. Rozwell, R.D. Kush, E. Helton, Saving Time and Money, Applied Clinical Trials, 2007.
11. C. Rozwell, R.D. Kush, E. Helton, CDISC Standards: Enabling Reuse without Rework, Applied Clinical Trials, 2006.
12. TM at Duke Clinical Research Institute. 2004.